Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Smooth Muscle | 3 | 2018 | 132 | 1.250 |
Why?
|
| Reactive Oxygen Species | 7 | 2016 | 480 | 0.920 |
Why?
|
| Resistin | 3 | 2018 | 14 | 0.890 |
Why?
|
| NADPH Oxidases | 4 | 2016 | 81 | 0.890 |
Why?
|
| Hypoxia | 9 | 2015 | 641 | 0.870 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2012 | 44 | 0.770 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2017 | 22 | 0.730 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 371 | 0.720 |
Why?
|
| Chemokine CCL11 | 1 | 2016 | 11 | 0.600 |
Why?
|
| Vascular Calcification | 1 | 2016 | 39 | 0.560 |
Why?
|
| Carotid Body | 7 | 2015 | 234 | 0.560 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 231 | 0.540 |
Why?
|
| Inflammation | 2 | 2017 | 920 | 0.490 |
Why?
|
| Up-Regulation | 4 | 2012 | 712 | 0.450 |
Why?
|
| Hydrogen Sulfide | 4 | 2015 | 50 | 0.430 |
Why?
|
| Protein Kinases | 2 | 2012 | 209 | 0.420 |
Why?
|
| Aging | 1 | 2016 | 691 | 0.420 |
Why?
|
| Neuropeptide Y | 2 | 2011 | 31 | 0.420 |
Why?
|
| Down-Regulation | 2 | 2010 | 504 | 0.400 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 32 | 0.390 |
Why?
|
| Adrenal Medulla | 1 | 2011 | 46 | 0.390 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2010 | 34 | 0.380 |
Why?
|
| Protein Phosphatase 2 | 1 | 2009 | 15 | 0.350 |
Why?
|
| Oxidative Stress | 3 | 2016 | 447 | 0.330 |
Why?
|
| Rats | 11 | 2014 | 3990 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2014 | 1219 | 0.300 |
Why?
|
| Antiporters | 2 | 2006 | 18 | 0.290 |
Why?
|
| Antigens, CD1 | 1 | 2006 | 35 | 0.290 |
Why?
|
| Listeriosis | 1 | 2006 | 84 | 0.280 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 139 | 0.280 |
Why?
|
| Interferon-beta | 1 | 2006 | 125 | 0.280 |
Why?
|
| Immunoglobulins | 2 | 2006 | 148 | 0.270 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2005 | 141 | 0.270 |
Why?
|
| Macrophages | 2 | 2018 | 554 | 0.240 |
Why?
|
| Oxygen | 3 | 2015 | 726 | 0.240 |
Why?
|
| Animals | 18 | 2016 | 26581 | 0.230 |
Why?
|
| Signal Transduction | 4 | 2017 | 3241 | 0.220 |
Why?
|
| Adrenal Cortex | 2 | 2012 | 21 | 0.210 |
Why?
|
| Angiotensin II | 2 | 2012 | 94 | 0.200 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1578 | 0.200 |
Why?
|
| Cystathionine gamma-Lyase | 4 | 2015 | 35 | 0.190 |
Why?
|
| Cell Hypoxia | 2 | 2011 | 164 | 0.180 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 64 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 2 | 2011 | 68 | 0.180 |
Why?
|
| Male | 15 | 2017 | 40956 | 0.160 |
Why?
|
| Brain Stem | 2 | 2009 | 165 | 0.160 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2015 | 44 | 0.160 |
Why?
|
| Antioxidants | 4 | 2013 | 223 | 0.160 |
Why?
|
| Metalloporphyrins | 3 | 2013 | 26 | 0.150 |
Why?
|
| Isoprostanes | 1 | 2016 | 4 | 0.150 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2016 | 6 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 88 | 0.140 |
Why?
|
| Tunica Intima | 1 | 2016 | 59 | 0.140 |
Why?
|
| Hyperplasia | 1 | 2016 | 148 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 154 | 0.140 |
Why?
|
| Endarterectomy, Carotid | 1 | 2016 | 73 | 0.140 |
Why?
|
| Cytokines | 2 | 2017 | 776 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 3092 | 0.130 |
Why?
|
| Carotid Arteries | 1 | 2016 | 127 | 0.130 |
Why?
|
| Carotid Stenosis | 1 | 2016 | 112 | 0.130 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2015 | 15 | 0.130 |
Why?
|
| Protein Kinase C | 1 | 2016 | 270 | 0.130 |
Why?
|
| Endothelin-1 | 2 | 2013 | 41 | 0.130 |
Why?
|
| Carotid Sinus | 2 | 2011 | 24 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2016 | 177 | 0.130 |
Why?
|
| Membrane Transport Proteins | 3 | 2006 | 166 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2016 | 236 | 0.120 |
Why?
|
| Adenosine Triphosphate | 3 | 2011 | 314 | 0.120 |
Why?
|
| Enzyme Activation | 3 | 2013 | 692 | 0.120 |
Why?
|
| Mice | 6 | 2016 | 11352 | 0.120 |
Why?
|
| Wound Healing | 1 | 2016 | 344 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2017 | 243 | 0.120 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 50 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 90 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 2013 | 45 | 0.120 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 66 | 0.110 |
Why?
|
| Adenosine Diphosphate | 2 | 2002 | 55 | 0.110 |
Why?
|
| Cell Movement | 1 | 2016 | 758 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 57 | 0.100 |
Why?
|
| Aldosterone | 1 | 2012 | 65 | 0.100 |
Why?
|
| Pressoreceptors | 1 | 2011 | 22 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 158 | 0.100 |
Why?
|
| Superior Cervical Ganglion | 1 | 2011 | 3 | 0.100 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cathepsin L | 1 | 2011 | 7 | 0.100 |
Why?
|
| Carboxypeptidase H | 1 | 2011 | 12 | 0.100 |
Why?
|
| Proprotein Convertase 1 | 1 | 2011 | 11 | 0.100 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 14 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2015 | 1106 | 0.100 |
Why?
|
| Apoptosis | 1 | 2018 | 1683 | 0.100 |
Why?
|
| Chromaffin Cells | 1 | 2011 | 37 | 0.100 |
Why?
|
| PC12 Cells | 1 | 2010 | 115 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2011 | 69 | 0.090 |
Why?
|
| Humans | 11 | 2018 | 86601 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 827 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2009 | 782 | 0.080 |
Why?
|
| Dopamine | 1 | 2009 | 275 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 103 | 0.080 |
Why?
|
| Antigens, CD1d | 1 | 2006 | 29 | 0.070 |
Why?
|
| HLA-B Antigens | 1 | 2006 | 35 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 134 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1135 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 268 | 0.070 |
Why?
|
| Aged | 3 | 2017 | 18402 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 425 | 0.070 |
Why?
|
| Hypertension | 1 | 2014 | 1141 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 267 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 879 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 203 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 728 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2005 | 460 | 0.060 |
Why?
|
| Middle Aged | 3 | 2017 | 25017 | 0.060 |
Why?
|
| Azides | 1 | 2002 | 11 | 0.060 |
Why?
|
| Peptides | 1 | 2006 | 639 | 0.060 |
Why?
|
| Catecholamines | 2 | 2014 | 88 | 0.060 |
Why?
|
| Respiration | 2 | 2015 | 262 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2002 | 108 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 819 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 122 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2818 | 0.050 |
Why?
|
| Potassium Chloride | 2 | 2012 | 87 | 0.050 |
Why?
|
| Spodoptera | 3 | 2006 | 32 | 0.050 |
Why?
|
| Female | 4 | 2017 | 44507 | 0.050 |
Why?
|
| Biomarkers | 2 | 2018 | 1718 | 0.050 |
Why?
|
| Substance P | 2 | 2011 | 61 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2002 | 666 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 673 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2012 | 639 | 0.040 |
Why?
|
| Calcium | 2 | 2015 | 1156 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 1924 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 164 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 54 | 0.040 |
Why?
|
| Protein Binding | 3 | 2006 | 1456 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2017 | 69 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 273 | 0.040 |
Why?
|
| Cell Line | 3 | 2006 | 2468 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 6501 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 63 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 116 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 302 | 0.030 |
Why?
|
| Gases | 1 | 2015 | 30 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 502 | 0.030 |
Why?
|
| Cysteine | 1 | 2015 | 135 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 339 | 0.030 |
Why?
|
| Splanchnic Nerves | 1 | 2014 | 7 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 270 | 0.030 |
Why?
|
| Stents | 1 | 2016 | 377 | 0.030 |
Why?
|
| Endothelin-Converting Enzymes | 1 | 2013 | 4 | 0.030 |
Why?
|
| Time Factors | 2 | 2017 | 5209 | 0.030 |
Why?
|
| Receptor, Endothelin A | 1 | 2013 | 22 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 444 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 615 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 239 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1185 | 0.030 |
Why?
|
| Cadmium Chloride | 1 | 2012 | 12 | 0.030 |
Why?
|
| Nifedipine | 1 | 2012 | 28 | 0.030 |
Why?
|
| Alkynes | 1 | 2012 | 17 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 589 | 0.030 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2012 | 5 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 459 | 0.030 |
Why?
|
| Receptors, Angiotensin | 1 | 2012 | 15 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 2012 | 28 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2012 | 20 | 0.030 |
Why?
|
| Sulfides | 1 | 2012 | 68 | 0.030 |
Why?
|
| Glycine | 1 | 2012 | 90 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 678 | 0.030 |
Why?
|
| Superoxides | 1 | 2012 | 73 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1673 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2012 | 125 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 21 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2012 | 80 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 203 | 0.030 |
Why?
|
| Time | 1 | 2011 | 77 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 187 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 271 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2011 | 176 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 214 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2377 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 989 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 428 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Amidine-Lyases | 1 | 2008 | 2 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 100 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 535 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4210 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1284 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1981 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2705 | 0.020 |
Why?
|
| HLA-B44 Antigen | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2426 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1143 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 5416 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 1513 | 0.020 |
Why?
|
| Temperature | 1 | 2006 | 396 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 250 | 0.020 |
Why?
|
| Protein Transport | 1 | 2005 | 411 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7988 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 736 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 144 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 305 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2232 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 557 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1920 | 0.010 |
Why?
|